Potassium Citrate Therapy of Nephrolithiasis

  • Charles Y. C. Pak
  • Beverley V. Adams
Part of the Topics in Renal Medicine book series (TIRM, volume 5)

Abstract

Potassium citrate is a new and exciting therapeutic modality introduced in 1985 for the management of a wide variety of stone-forming disorders. It has reawakened interest in the deranged citrate metabolism in nephrolithiasis and in the physicochemical effects of citrate in stone formation. It has substantially expanded our capability for an effective medical control of stone disease. The approval of this drug in the United States represented a culmination of our seven years of extensive laboratory and clinical work. This chapter will review this work pertaining to: (1) physicochemical action of citrate, (2) physiological effect of potassium citrate, (3) physicochemical effect of potassium citrate, (4) long-term clinical trial with potassium citrate and safety of potassium citrate.

Keywords

Fatigue Crystallization Phosphorus Citrate Oxalate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pak, C.Y. C. 1978. Calcium urolithiasis: pathogenesis, diagnosis and management. New York: Plenum Publishing, pp. 5–36.Google Scholar
  2. 2.
    Pak, C.Y.C., Hayashi, Y., Finlayson, B. and Chu, S. 1977. Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J. Lab. Clin. Med. 89:891–901.PubMedGoogle Scholar
  3. 3.
    Pak, C. Y. C. and Holt, K. 1976. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25:665–673.PubMedCrossRefGoogle Scholar
  4. 4.
    Pak, C. Y. C. and Galosy, R. A. 1980. Urinary FPR-APR discriminant score for the quantitative assessment of the propensity for spontaneous nucleation of calcium oxalate. Am. J. Med. 69:681–689.PubMedCrossRefGoogle Scholar
  5. 5.
    Nicar, M.J., Hill, K. and Pak, C. Y. C. 1983. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. Metabolism 32:906–910.PubMedCrossRefGoogle Scholar
  6. 6.
    Pak, C. Y. C, Sakhaee, K. and Fuller, C. 1986. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 30:422–428.PubMedCrossRefGoogle Scholar
  7. 7.
    Pak, C. Y. C, Nicar, M. and Northcutt, C. 1982. The definition of the mechanism of hyper-calciuria is necessary for the treatment of recurrent stone formers. In Contributions to Nephrology, G.M. Berlyne, S. Giovannetti and S. Thomas (eds.). Basel: S. Karger, pp. 136–151.Google Scholar
  8. 8.
    Kok, D.J., Papapoulos, S.E. and Bijvoet, O.L.M. 1986. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1:1056–1058.PubMedCrossRefGoogle Scholar
  9. 9.
    Finlayson, B. and Smith, A. 1974. Stability of first dissociable proton of uric acid. J. Chem. Eng. Data. 19:94–97.CrossRefGoogle Scholar
  10. 10.
    Nicar, M.J., Skurla, C, Sakhaee, K. and Pak, C. Y. C. 1983. Low urinary citrate excretion in nephrolithiasis. Urology 21:8–14.PubMedCrossRefGoogle Scholar
  11. 11.
    Menon, M. and Mahle, C.J. 1983. Urinary citrate excretion in patients with renal calculi. J. Urol. 129:1158–1160.PubMedGoogle Scholar
  12. 12.
    Schwille, P.O., Scholz, D., Schwüle, K., Leutschaft, R., Goldberg, I. and Sigel, A. 1982. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Nephron 31:194–202.PubMedCrossRefGoogle Scholar
  13. 13.
    Nicar, M.J., Peterson, R. and Pak, C.Y. C. 1984. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J. Urol. 131:430–433.PubMedGoogle Scholar
  14. 14.
    Pak, C. Y.C., Skurla, C, Brinkley, L. and Sakhaee, K. 1984. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship. J. Clin. Pharmacol. 24:19–26.PubMedGoogle Scholar
  15. 15.
    Sakhaee, K., Nicar, M., Hill, K. and Pak, C.Y. C. 1983. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 24:348–352.PubMedCrossRefGoogle Scholar
  16. 16.
    Preminger, G. M., Sakhaee, K., Skurla, C. and Pak, C.Y. C. 1985. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J. Urol. 134:20–23.PubMedGoogle Scholar
  17. 17.
    Pak, C.Y.C., Peterson, R., Sakhaee, K., Fuller, C, Preminger, G. and Reisch, J. 1985. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am. J. Med. 79:284–288.PubMedCrossRefGoogle Scholar
  18. 18.
    Nicar, M.J., Hsu, M.C. and Fetner, C. 1986. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Clin. Ther. 8:219–225.PubMedGoogle Scholar
  19. 19.
    Pak, C. Y. C, Fuller, C, Sakhaee, K., Preminger, G. and Britton, F. 1985. Long-term treatment of calcium nephrolithiasis with potassium citrate. J. Urol. 134:11–19.PubMedGoogle Scholar
  20. 20.
    Yendt, E.R. and Cohanim, M. 1978. Prevention of calcium stones with thiazides. Kidney Int. 13:397–409.PubMedCrossRefGoogle Scholar
  21. 21.
    Kassirer, J. P., Berkman, P. M., Lawrenz, D. R. and Schwartz, W. B. 1965. The critical role of chloride in the correction of hypokalemic alkalosis in man. Am. J. Med. 38:172–189.PubMedCrossRefGoogle Scholar
  22. 22.
    Pak, C.Y.C. 1985. Renal calculi. In Cecil Textbook of Medicine, J.B. Wyngaarden, L.H. Smith, Jr. and F. Plum (eds.). Philadelphia W.B. Saunders Co., pp. 628–633.Google Scholar
  23. 23.
    Pak, C.Y.C, Peters, P., Hurt, G., Kadesky, M., Fine, M., Reisman, D., Splann, F., Caramela, C, Freeman, A., Britton, F., Sakhaee, K. and Breslau, N.A. 1981 Is selective therapy of recurrent nephrolithiasis possible? Am. J. Med. 71:615–622.PubMedCrossRefGoogle Scholar
  24. 24.
    Pak, C.Y.C. and Fuller, C. 1986. Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann. Intern. Med. 104:33–37.PubMedGoogle Scholar
  25. 25.
    Pak, C. Y.C., Britton, F., Peterson, R., Ward, D., Northcutt, C, Breslau, N. A., McGuire, J., Sakhaee, K., Bush, S., Nicar, M., Norman, D.A. and Peters, P. 1980. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am. J. Med. 69:19–30.PubMedCrossRefGoogle Scholar
  26. 26.
    Pak, C.Y. C, Holt, K. and Zerwekh, J.E. 1979. Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation. Invest. Urol. 17:138–140.PubMedGoogle Scholar
  27. 27.
    Pak, C. Y. C. and Peterson, R. 1986. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch. Intern. Med. 146:863–868.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Charles Y. C. Pak
  • Beverley V. Adams

There are no affiliations available

Personalised recommendations